Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Triptorelin Drug market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Triptorelin Drugmarket, defines the market attractiveness level of Triptorelin Drug market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Triptorelin Drug industry, describes the types of Triptorelin Drug market, the applications of major players and the market size, and deeply analyzes the current situation of the global Triptorelin Drug market and the development prospects and opportunities of Triptorelin Drug industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Triptorelin Drug market in Chapter 13.
By Player:
Debiopharm Group
Xbrane Biopharma
Ferring
Chengdu Tiantaishan pharmaceutical
Allergan
Arbor Pharmaceuticals
Ipsen
By Type:
375 mg Vial
1125 mg Vial
225 mg Vial
By End-User:
Advanced prostate cancer
Endometriosis
Uterine fibroids
Precocious puberty
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Triptorelin Drug Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Triptorelin Drug Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Triptorelin Drug Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Triptorelin Drug Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Triptorelin Drug Market Analysis and Outlook to 2022
-
7.1 Global Triptorelin Drug Consumption (2017-2022)
-
7.2 United States Triptorelin Drug Consumption (2017-2022)
-
7.3 Europe Triptorelin Drug Consumption (2017-2022)
-
7.4 China Triptorelin Drug Consumption (2017-2022)
-
7.5 Japan Triptorelin Drug Consumption (2017-2022)
-
7.6 India Triptorelin Drug Consumption (2017-2022)
-
7.7 South Korea Triptorelin Drug Consumption (2017-2022)
8 Region and Country-wise Triptorelin Drug Market Analysis and Outlook to 2028
-
8.1 Global Triptorelin Drug Consumption Forecast (2022-2028)
-
8.2 United States Triptorelin Drug Consumption Forecast (2022-2028)
-
8.3 Europe Triptorelin Drug Consumption Forecast (2022-2028)
-
8.4 China Triptorelin Drug Consumption Forecast (2022-2028)
-
8.5 Japan Triptorelin Drug Consumption Forecast (2022-2028)
-
8.6 India Triptorelin Drug Consumption Forecast (2022-2028)
-
8.7 South Korea Triptorelin Drug Consumption Forecast (2022-2028)
9 Global Triptorelin Drug Market Outlook by Types and Applications to 2022
-
9.1 Global Triptorelin Drug Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global 375 mg Vial Consumption and Growth Rate (2017-2022)
-
9.1.2 Global 1125 mg Vial Consumption and Growth Rate (2017-2022)
-
9.1.3 Global 225 mg Vial Consumption and Growth Rate (2017-2022)
-
9.2 Global Triptorelin Drug Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Advanced prostate cancer Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Endometriosis Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Uterine fibroids Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Precocious puberty Consumption and Growth Rate (2017-2022)
10 Global Triptorelin Drug Market Outlook by Types and Applications to 2028
-
10.1 Global Triptorelin Drug Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global 375 mg Vial Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global 1125 mg Vial Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global 225 mg Vial Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Triptorelin Drug Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Advanced prostate cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Endometriosis Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Uterine fibroids Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Precocious puberty Consumption Forecast and Growth Rate (2022-2028)
11 Global Triptorelin Drug Import and Export Analysis (Top 5 Countries)
-
11.1 Global Triptorelin Drug Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Triptorelin Drug Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Triptorelin Drug Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Triptorelin Drug Market Competitive Analysis
-
14.1 Debiopharm Group
-
14.1.1 Debiopharm Group Company Details
-
14.1.2 Debiopharm Group Triptorelin Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Debiopharm Group Triptorelin Drug Product and Service
-
14.2 Xbrane Biopharma
-
14.2.1 Xbrane Biopharma Company Details
-
14.2.2 Xbrane Biopharma Triptorelin Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Xbrane Biopharma Triptorelin Drug Product and Service
-
14.3 Ferring
-
14.3.1 Ferring Company Details
-
14.3.2 Ferring Triptorelin Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Ferring Triptorelin Drug Product and Service
-
14.4 Chengdu Tiantaishan pharmaceutical
-
14.4.1 Chengdu Tiantaishan pharmaceutical Company Details
-
14.4.2 Chengdu Tiantaishan pharmaceutical Triptorelin Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Chengdu Tiantaishan pharmaceutical Triptorelin Drug Product and Service
-
14.5 Allergan
-
14.5.1 Allergan Company Details
-
14.5.2 Allergan Triptorelin Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Allergan Triptorelin Drug Product and Service
-
14.6 Arbor Pharmaceuticals
-
14.6.1 Arbor Pharmaceuticals Company Details
-
14.6.2 Arbor Pharmaceuticals Triptorelin Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Arbor Pharmaceuticals Triptorelin Drug Product and Service
-
14.7 Ipsen
-
14.7.1 Ipsen Company Details
-
14.7.2 Ipsen Triptorelin Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Ipsen Triptorelin Drug Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Triptorelin Drug
-
Figure Triptorelin Drug Picture
-
Table Global Triptorelin Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Triptorelin Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Triptorelin Drug Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Triptorelin Drug Consumption by Country (2017-2022)
-
Figure United States Triptorelin Drug Consumption and Growth Rate (2017-2022)
-
Table Europe Triptorelin Drug Consumption and Growth Rate (2017-2022)
-
Figure China Triptorelin Drug Consumption and Growth Rate (2017-2022)
-
Figure Japan Triptorelin Drug Consumption and Growth Rate (2017-2022)
-
Figure India Triptorelin Drug Consumption and Growth Rate (2017-2022)
-
Figure South Korea Triptorelin Drug Consumption and Growth Rate (2017-2022)
-
Figure Global Triptorelin Drug Consumption Forecast by Country (2022-2028)
-
Figure United States Triptorelin Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Triptorelin Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Triptorelin Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Triptorelin Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Triptorelin Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Triptorelin Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global 375 mg Vial Consumption and Growth Rate (2017-2022)
-
Figure Global 1125 mg Vial Consumption and Growth Rate (2017-2022)
-
Figure Global 225 mg Vial Consumption and Growth Rate (2017-2022)
-
Figure Global Advanced prostate cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Endometriosis Consumption and Growth Rate (2017-2022)
-
Figure Global Uterine fibroids Consumption and Growth Rate (2017-2022)
-
Figure Global Precocious puberty Consumption and Growth Rate (2017-2022)
-
Figure Global 375 mg Vial Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global 1125 mg Vial Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global 225 mg Vial Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Advanced prostate cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Endometriosis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Uterine fibroids Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Precocious puberty Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Triptorelin Drug Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Triptorelin Drug Export by Region (Top 5 Countries) (2017-2028)
-
Table Debiopharm Group (Foundation Year, Company Profile and etc.)
-
Table Debiopharm Group Triptorelin Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Debiopharm Group Triptorelin Drug Product and Service
-
Table Xbrane Biopharma (Foundation Year, Company Profile and etc.)
-
Table Xbrane Biopharma Triptorelin Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Xbrane Biopharma Triptorelin Drug Product and Service
-
Table Ferring (Foundation Year, Company Profile and etc.)
-
Table Ferring Triptorelin Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Ferring Triptorelin Drug Product and Service
-
Table Chengdu Tiantaishan pharmaceutical (Foundation Year, Company Profile and etc.)
-
Table Chengdu Tiantaishan pharmaceutical Triptorelin Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Chengdu Tiantaishan pharmaceutical Triptorelin Drug Product and Service
-
Table Allergan (Foundation Year, Company Profile and etc.)
-
Table Allergan Triptorelin Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Allergan Triptorelin Drug Product and Service
-
Table Arbor Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Arbor Pharmaceuticals Triptorelin Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Arbor Pharmaceuticals Triptorelin Drug Product and Service
-
Table Ipsen (Foundation Year, Company Profile and etc.)
-
Table Ipsen Triptorelin Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Ipsen Triptorelin Drug Product and Service
-
